In-depth cytogenetic and immunohistochemical analysis in a real world cohort - reconsidering the role of primary and secondary aberrations in multiple myeloma
Sina Wenger,
Milena Pantic,
Gabriele Ihorst,
Stepan Cysar,
Marc-Antoine Calba,
Christine Greil,
Ralph Wäsch,
Monika Engelhardt
Affiliations
Sina Wenger
Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg
Milena Pantic
Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg
Gabriele Ihorst
Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany; Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Freiburg
Stepan Cysar
Department of Pathology, Faculty of Medicine, University of Freiburg, Freiburg
Marc-Antoine Calba
Department of Pathology, Faculty of Medicine, University of Freiburg, Freiburg
Christine Greil
Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg
Ralph Wäsch
Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg
Monika Engelhardt
Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg
